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seems to be one of the most important factors affecting
cell proliferation and may be one of the components of
carcinogenesis that results in proliferation-dominant
cell kinetics.
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Introduction
The evolution of Helicobacter pylori-associated gastric
cancer begins with superficial gastritis that progresses
to chronic gastritis, atrophy with islands of intestinal
metaplasia (IM), development of dysplasia, and, finally,
frank carcinoma.1–4 There is strong evidence that H.
pylori infection alters the kinetic pattern of the gastric
glandular epithelium. Effects of the infection on gastric
mucosal epithelial cell turnover are thought to contrib-
ute to the process of carcinogenesis, with disturbances
in the balance between cellular proliferation and
apoptosis predisposing to either cell loss with mucosal
damage or cell accumulation and cancer development.
Recent studies suggest that H. pylori infection in-
duces cell apoptosis, a genetically regulated form of
programmed cell death.5–9 Moss et al.9 reported that
gastric epithelial apoptosis was enhanced in duodenal
ulcer patients with H. pylori infection and that the in-
creased number of apoptotic cells returned to normal
after H. pylori eradication. On the other hand, other
studies have reported that H. pylori infection is not
associated with significant changes in gastric epithelial
apoptosis, because there is wide variability in the
apoptotic indices of both H. pylori-positive and
-negative patients.10
The aim of this study was to compare apoptosis and
proliferation in the non-cancer-containing mucosa of
patients with early gastric cancer with these phenomena
Background. Gastric cancer is typically an end result
of Helicobacter pylori-associated chronic gastritis. The
pathogenesis is thought to involve effects on gastric
mucosal epithelial cell turnover. In this study, we
aimed to compare apoptosis and proliferation in the
noncancer-containing mucosa of H. pylori-positive
patients with early gastric cancer with these phenomena
in H. pylori-positive controls. Methods. Two specimens
each were obtained from the greater and lesser curva-
tures of the corpus and from the greater curvature
of the antrum. The histopathological grading used was
the updated Sydney System. Apoptotic epithelial cells
were detected using the terminal deoxy nucleotidyl
transferase-mediated deoxy-uridine triphosphate
(dUTP) biotin nick-end labeling (TUNEL) method.
The expression of Ki 67 was evaluated by immunos-
taining. Results. Forty-five H. pylori-positive patients
with endoscopic mucosal resection for early gastric can-
cer and 52 H. pylori-positive controls were studied.
Gastric cancer was associated with a higher frequency
of incomplete intestinal metaplasia (IM; odds ratio
[OR], 19.1; 95% confidence interval [CI], 6.9–53.2;
P  0.001). The apoptotic index (AI) in the greater
curvature of the corpus and the proliferation index (PI)
in each part were significantly higher in cancer patients
than in the control group. The median PI in the antrum
was significantly higher in the incomplete IM group
than that in the complete IM group (17.6 vs 12.6;
P  0.009). The PI and the AI in the greater curvature
of the corpus correlated with the activity score, and the
PI correlated with the IM score. Conclusions. In the
cancer patients, H. pylori-induced gastritis was associ-
ated with increased cell proliferation and apoptosis
compared with mucosal findings in the controls. IM
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in H. pylori-positive controls. We also assessed the
relationship between cell turnover and histological
findings.
Methods
This was a case-control study of patients with a history
of endoscopic mucosal resection (EMR) for early gas-
tric cancer. The study was performed in Japan, at the
Osaka Medical Center for Cancer and Cardiovascular
Diseases and at Aishinkai Nakae Hospital. Patients
were enrolled for the study between November 2001
and June 2003.
Patients
H. pylori-positive patients with a medical history of
EMR for early stage, noncardiac intestinal type of
gastric cancer without lymph node metastasis, and H.
pylori-positive, age- and sex-matched control patients
were eligible for participation. Patients were excluded
if they had had eradication therapy for H. pylori infec-
tion; used anti-secretory drugs or nonsteroidal anti-
inflammatory drugs (NSAIDs); or had hemorrhagic
diseases, insulin-dependent diabetes mellitus, cirrhosis,
or renal failure. Demographic data collected at study
entry included age, sex, smoking habits, alcohol con-
sumption, and drug treatments, including the use of
anti-secretory drugs. Drinking and smoking were
defined as regular intake when consumption was more
than 35 g of ethanol or 5 cigarettes or more per day,
respectively. The study was approved by the Osaka
Medical Center for Cancer and Cardiovascular
Diseases Ethics Committee, and informed consent was
obtained from each patient.
Histopathological grading
Endoscopies were performed by experienced endo-
scopists after the patients had had a 12-h fast. Two
specimens each were obtained from the greater curva-
ture of the antrum and the greater and lesser curvature
of the corpus. The specimens were stained with hema-
toxylin and eosin, and additionally stained with Giemsa
to score H. pylori density. A visual analogue scale,
graded from 0 (absent/normal) to 3 (maximal intensity)
was used for the following parameters: activity of gastri-
tis (granulocytic infiltration), inflammation (lympho-
cytic and plasma cells infiltration), glandular atrophy,
IM, and H. pylori density, according to the updated
Sydney classification.11 Well-oriented tissue sections
with gastric pits and glands cut longitudinally and visible
along the entire isthmus zone were selected for quanti-
tative analysis. Histopathological grading was deter-
mined twice for each slide, by a single pathologist who
was blinded to the previous histological scores and
other experimental results. Average histological scores
were used to analyze the data.
Diagnosis of H. pylori infection
Venous blood samples were analyzed for specific IgG
H. pylori antibodies with an enzyme-linked immuno-
sorbent assay (ELISA) kit, using the E plate test (Eiken
Kagaku, Tokyo, Japan). Patients were considered to be
infected with H. pylori if the serum test was positive or
if chronic gastritis/atrophy with H. pylori was histo-
pathologicaly present.
Subtyping IM
Samples were also stained with Alcian blue (AB)/high
iron diamine (HID) to categorize IM as complete type
(type I) or incomplete type (types II and III). The slides
were immersed in HID solution for 20 h at room tem-
perature, then rinsed with deionized water and stained
with 1% AB (pH 2.5) for 2 min.
Immunohistochemistry
Three adjacent sections, 4-µm-thick, were cut onto each
of three polylysine-coated glass slides. The sections
were deparaffinized, washed in phosphate-buffered
saline (PBS), and autoclaved for 10 min in sodium cit-
rate buffer for antigenic retrieval. For immunostaining,
sections were incubated with mouse monoclonal
anti-human Ki-67 (DAKO; Carpinteria, CA, USA) at a
dilution of 1 : 100 at room temperature for 1h. After
a washing in PBS, the sections were incubated for 1 h
with an anti-mouse immunoglobulin conjugated to
horseradish peroxidase dextran-labeled polymer, using
an EnVision peroxidase mouse system (DAKO). The
sections were washed in PBS, stained in 0.05%
diaminobenzidine hydrochrolide (DAB) solution for
5 min, then counterstained with hematocxylin. After
dehydration with xylene, the sections were mounted
under a glass coverslip. More than 500 cells along the
proliferation zone were counted, and Ki-67-positive
cells were expressed as a percentage of the total number
of cells, as the proliferative index (PI).
Detection of apoptotic cells
Apoptotic cells were detected by the terminal
deoxynucleotidyl transferase-mediated deoxyuridine
triphosphate (dUTP) biotin nick-end labeling
(TUNEL) method, using Apoptag fluorescein direct in
situ apoptosis detection kits (ApopTag; Intergen, New
York, NY, USA) according to the manufacturer’s pro-
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tocol. The nuclei in all cells (red color shown in Fig. 1c)
were stained by 0.25mg/ml propidium iodide. Five
hundred gastric epithelial cells in the foveolar region
of longitudinally sectioned gastric pits were counted.
The apoptotic index (AI) was defined as the ratio of
TUNEL-positive cells (green color) to the total number
of nuclei (red color), multiplied by 100 (Fig. 1c).
Statistical analysis
Values were expressed as medians and ranges.
Mantel-2 analyses and the nonparametric Mann-
Whitney U-test were performed to measure differences
in demographic and clinical characteristics. The
Kruskal-Wallis test was used for comparisons among
groups, and statistical analysis for significant differences
between two groups was performed using the nonpara-
metric Mann-Whitney U-test. Linear correlations
between parameters were performed by Spearman
correlation analysis. A two-sided P value of less than
0.05 was considered statistically significant. All statisti-
cal computations were performed using SPSS for Win-
dows 11.0 (SPSS; Chicago, IL, USA).
Results
Initially 60 subjects were enrolled in the cancer group
and 60 sex- and age-matched subjects were enrolled in
the control group. However, 3 subjects in the cancer
group were excluded because of a history of eradication
therapy, and an additional 20 subjects (12 from the can-
cer group, 8 from controls) were excluded because of
biopsy sample errors. The study groups thus consisted of
45 H. pylori-positive patients with EMR for early gastric
cancer and 52 H. pylori-positive controls. Demographic
and clinical characteristics of the study groups are shown
in Table 1. Incomplete IM was present in 36 patients
Fig. 1a–c. Representative immunohistochemical staining
for Ki67 and apoptosis in the gastric mucosa. Ki-67 antigen-
labelled cells were detected in the isthmic portion of gastric
pits in Helicobacter pylori-positive controls (a), and expres-
sion of Ki67 was observed in the background mucosa of
gastric cancer subjects exhibiting atrophic gastritis and in-
testinal metaplasia (b). c Scattered apoptotic cells (arrows)
in the greater curvature of the corpus in the cancer group
were detected by terminal deoxynucleotidyl transferase-
mediated deoxyuridine triphosphate (dUTP) biotin nick-
end labeling (TUNEL). The nuclei in all cells (red color)
were stained by propidium iodide. a and b EnVision peroxi-
dase system (DAKO), 40; c 250
a b
c
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(80%) in the cancer group and in 9 (17.3%) of the H.
pylori-positive controls. More patients in the gastric can-
cer group belonged to the incomplete IM group, and this
difference between the two groups was highly significant
(P  0.001). Gastric cancer was associated with a higher
frequency of incomplete IM (odds ratio [OR], 19.1; 95%
confidence interval [CI], 6.9–53.2; P  0.001). Malignant
lesions were located in the antrum in 24 patients, and 15
patients had lesions in the corpus or angularis. In the
remaining 6 patients, malignant lesions were found in
both locations. No malignant lesion was located in the
greater curvature of the corpus.
The scores for inflammation in the greater curva-
ture of the corpus (P  0.03), the scores for atrophy in
the lesser curvature of the corpus (P  0.001), and
the scores for IM in each part of the stomach were
significantly higher in the cancer group than in the con-
trol group. The scores for H. pylori in the antrum (P 
0.002) and in the lesser curvature of the corpus (P 
0.007) were lower in the cancer group than in the con-
trol group (Table 2).
The PI in each part of the stomach (P  0.001 in the
lesser curvature of the corpus) and the AI in the greater
curvature of the corpus (P  0.02) were significantly
higher in patients with gastric cancer than these values
in the controls (Fig. 2). The median PI in the antrum
was significantly higher (17.6 vs 12.6; P  0.009) in the
incomplete-type IM group than that in the complete-
type IM group (Fig. 3). However, the AI was not differ-
ent between these two groups.
The PI in the greater curvature of the corpus was
significantly correlated with the score for activity (r 
0.47; P  0.001) and the PI values in each part were
correlated with the scores for atrophy and IM (IM, r 
0.52; P  0.001 in the lesser curvature of the corpus; Fig.
4a). The AI was correlated with the score for activity (r
 0.36; P  0.001) in the greater curvature of the corpus
(Fig. 4b; Table 3).
The median scores for H. pylori in the greater curva-
ture of the corpus were significantly higher (1.0 vs 0.5; P
 0.006) in patients with malignant lesions located in
the antrum than the scores in patients with lesions in the
corpus or angularis. The median scores for inflamma-
tion (2.5 vs 2.0; P  0.06) and PI (11.0 vs 10.3; P  0.06)
in the greater curvature of the corpus also tended to be
higher in the antrum group. However, the scores for
atrophy, IM, and AI were not different between the
upper-stomach group and the antrum group.
Discussion
Gastric cancer is the end result of H. pylori-related
mucosal inflammation. The extent and location of atro-
phy and IM along the lesser curvature from the cardia to
the prepyloric zone identifies patients with the highest
cancer risk.12 Initially, inflammation in the antrum forms
a favorable environment for H. pylori, whereas the on-
set of atrophy and IM results in a less favorable environ-
ment and a reduction in the bacterial load13 that may
result in complete loss of H. pylori and a reversion of
H. pylori seropositivity to seronegativity. Therefore,
we focused on only H. pylori-positive patients and ex-
cluded those in whom the amount of gastric damage had
already led to an absence of active H. pylori infection.
We believe that this allowed a more valid comparison of
epithelial cell turnover in patients with or without gas-
tric cancer.
Table 1. Patient demographic and clinical characteristics
Controls Patients with
(n  52) cancer (n  45)
Age, in years; mean (SE) 70 (1) 68 (1)
Sex; male/female 42/10 35/10
Current smokers 25.0% 18.2%
Regular alcohol intake 40.4% 46.7%
Type of intestinal metaplasia; 19/24/9 2/7/36
non/complete/incomplete*
* P  0.001 by Pearson 2 test
Table 2. Comparison of scores for histological findings between the control group and the cancer group
Antrum             CLC                CGC
AC IF AT IM HP AC IF AT IM HP AC IF AT IM HP
Control group
Median 1.5 2.0 1.0 0.0 1.0 1.5 2.0 2.0 1.0 1.0 1.25 2.0 0.5 0 1.0
Range 0–3 0–3 0–2.5 0–2.5 0–3 0–3 0–3 0–3 0–3 0–3 0–3 0–3 0–3 0–3 0–3
Cancer group
Median 1.0 2.0 1.25 1.0 0.5 1.0 1.5 2.5 2.0 0.5 2.0 2.5 1.0 1.0 1.0
Range 0–3 0–3 0–3 0–3 0–3 0–3 0–3 0–3 0–3 0–3 0–3 0–3 0–3 0–3 0–3
P value 0.56 0.48 0.08 0.001 0.002 0.87 0.81 0.001 0.001 0.007 0.06 0.03 0.39 0.001 0.06
P values by Mann-Whitney U-test
CLC, lesser curvature of corpus; CGC, greater curvature of corpus; AC, activity; IF, inflammation; AT, atrophy; IM, intestinal metaplasia; HP,
Helicobacter pylori
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Although H. pylori infection is known to be associ-
ated with increased gastric epithelial cell proliferation,
induction of apoptosis, and inhibition of DNA synthe-
sis,7 the overall findings of its effect cell kinetics have
been conflicting.14 This may be due, in part, to dif-
ferences in the infecting strains of H. pylori or to the
different clinical presentations which are associated
with different patterns of gastritis. For example, it has
been suggested that patients infected by H. pylori
cagA- or babA2-positive strains have increased pro-
liferation among gastric cells compared to patients
infected by cagA- or babA2-negative H. pylori.15,16
Another major reason for different conclusions re-
garding the effects of H. pylori on cell kinetics may be
related to the underlying histologic pattern. Some pre-
vious studies had reported that cell proliferation and
apoptosis were correlated with inflammation.16–19 How-
ever, in the present study, the PI was most significantly
associated with IM rather than with inflammation in the
lesser curvature of the corpus. The PI and the IM score
in each part of the stomach were significantly higher in
patients with gastric cancer than these values in the
controls. In contrast, the AI and scores for inflammation
only in the greater curvature of corpus were signifi-
cantly higher in the cancer group than in the controls,
while the AI in the other parts tended to be lower in
the cancer group. IM and inflammation accelerate cell
proliferation; however, only inflammation induces
apoptosis. Moreover, the treated gastric tumors in our
patients had not existed in the greater curvature of the
corpus (where the PI was relatively low and the AI was
relatively high compared with PI and AI at other sites).
Fig. 2. The proliferation index and
apoptotic index in patients with gastric
cancer and controls. The ends of the
boxes define the 25th and 75th percen-
tiles, with the bold lines showing the me-
dian values, and error bars defining the
10th and 90th percentiles. *P  0.05;
**P  0.01; ***P  0.001 by nonpara-
metric Mann-Whitney U-test. AT, an-
trum; CLC, lesser curvature of corpus;
CGC, greater curvature of corpus. White
bars, controls; gray bars, patients with
cancer
Fig. 3. The proliferation index in patients with complete intes-
tinal metaplasia (white bars) and incomplete intestinal meta-
plasia (gray bars). The ends of the boxes define the 25th and
75th percentiles, with the bold lines showing the median
values, and error bars defining the 10th and 90th percentiles.
**P  0.01 by nonparametric Mann-Whitney U-test. AT,
antrum; CLC, lesser curvature of corpus; CGC, greater curva-
ture of corpus
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IM seems to be one of the most important factors affect-
ing gastric mucosal cell proliferation, and this condition
leads to proliferation-dominant cell kinetics, which may
one of the components contributing to carcinogenesis.
Other recent studies have suggested that the develop-
ment of IM is associated with the impaired regulation
of gastric epithelial proliferation, which is not rever-
sible following H. pylori eradication in areas where
the oncoprotein p21ras is expressed.20,21 Apoptosis
associated with H. pylori is also associated with
increased epithelial proliferation, whereas, in areas of
IM or dysplasia, proliferation remains increased but
apoptosis reverts to normal levels following H. pylori
eradication.5,22–25
Gastric IM is categorized into three types: I
(complete), and II and III (incomplete). Type III IM
typically shows the greatest genetic changes. Moreover,
patients with type III IM are likely to be at a higher risk
of gastric cancer.26 Thus, type III IM may be implicated
in the severe imbalance of proliferation and apoptosis in
the precancerous lesions.27 In the present study, more
patients in the gastric cancer group compared to the
control group belonged to the incomplete IM group,
and the PI in the antrum was significantly higher in the
incomplete IM group than in the complete IM group.
Although an endoscopic follow-up study of patients
with IM has reported the disappearance of IM, this
result may be due to sampling error, as neither the
presence nor the type of IM were consistent when endo-
scopic biopsies were repeated in the same regions of the
stomach.28 However, when IM is extensive in the cor-
pus, it is likely to be identified in biopsy materials, such
Fig. 4. a Correlation between the proliferation index and the score of intestinal metaplasia in the lesser curvature of the corpus.
b Correlation between the apoptotic index and the score of activity in the greater curvature of the corpus
Table 3. Correlations between the scores for histological parameters
AC IF Atrophy IM HP PI
PI
AT 0.05 0.05 0.19 0.32** 0.24*
CLC 0.07 0.06 0.43*** 0.52*** 0.19
CGC 0.47*** 0.40*** 0.18 0.28** 0.36**
AI
AT 0.26* 0.09 0.13 0.05 0.02 0.10
CLC 0.23* 0.25* 0.02 0.10 0.21* 0.01
CGC 0.36*** 0.30** 0.17 0.05 0.06 0.27*
P values by Spearman correlation analysis; *P  0.05; **P  0.01; *** P  0.001
AT, antrum; CLC, lesser curvature of corpus; CGC, greater curvature of corpus; AC, activity; IF,
inflammation; IM, intestinal metaplasia; HP, Helicobacter pylori; PI, proliferation index; AI,
apoptotic index
a b
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that the finding of IM in the corpus is a marker of corpus
atrophy.
There are two other studies comparing epithelial cell
turnover in patients with and without gastric cancer,
reporting conflicting results on cell kinetics.29,30 One
study29 reported that the AI in the corpus, which
correlates with the grade of glandular atrophy, was sig-
nificantly higher in patients with intestinal-type cancer
compared with controls. The PI was not significantly
different between these groups.29 However, the number
of their cancer subjects was small (n  32) and may
be inadequate for statistical purposes. The other study30
reported that the PI in the greater curvature of the
corpus and the lesser curvature of the antrum was
higher in 63 cancer patients than in 97 H. pylori-positive
nonulcer dyspepsia subjects. The AI in the cancer group
was lower at all sites, including the greater curvature
of corpus.30 One possible reason for the difference
between this study’s findings,30 and our results could be
the discrepancy in ages between their cancer and con-
trol groups. Moreover, in our study, only early and
intestinal types of gastric cancer were evaluated.
Histologically, gastric cancers have been classified into
two main histological types, diffuse and intestinal,
which have differing characteristics and possibly dif-
fering pathogenesis. Diffuse-type gastric cancer arises
independently of IM, and the AI in cancer lesions is
significantly higher in intestinal-type than in diffuse car-
cinoma. However, the PI is higher in diffuse compared
to intestinal tumors.31
In patients with malignant lesions located in the an-
trum, the scores for H. pylori were much higher than the
scores for inflammation, and the PI tended to be higher
in the greater curvature of corpus, where the scores for
atrophy and IM were not different compared with those
in the upper stomach. The gastritis in the greater curva-
ture of the corpus induced by H. pylori is probably
associated with the development of gastric cancer, espe-
cially in the antrum, and there may be site-specific
differences characteristic and possibly pathogenetic of
gastric cancer. A larger-scale investigation to study the
cancer phenotype is needed to confirm site-specificity.
In patients with gastric cancer, severe inflammation
still exists in the greater curvature of the corpus, accel-
erating the gastric mucosal cell turnover. However, at
other sites, especially the lesser curvature of the corpus,
where severe glandular atrophy has developed, IM oc-
curs, accompanied by a reduction of H. pylori density,
resulting in the same type of imbalance between cell
apoptosis and proliferation as that seen in neoplasia.
Therefore, in conclusion, it appears that H. pylori-
induced gastritis is associated with increased cell prolif-
eration and apoptosis, and likely results in atrophy and
IM, leading to gastric cancer. IM seems to be one of the
most important factors affecting cell proliferation, and
may be components of carcinogenesis that results in
proliferation-dominant cell kinetics.
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